Amiloride (MK-870): Transforming Sodium Channel Research Workflows

Principle and Setup: The Dual Mechanism of Amiloride (MK-870)

Amiloride (MK-870), available from APExBIO, is a powerful biochemical reagent recognized for its dual inhibitory action on epithelial sodium channels (ENaC) and urokinase-type plasminogen activator receptors (uPAR). As an epithelial sodium channel inhibitor and urokinase-type plasminogen activator receptor inhibitor, Amiloride uniquely enables researchers to dissect ion transport phenomena and receptor-mediated signaling in diverse cell models. Its role as an ion channel blocker extends to modulating PC2 channels, thereby impacting sodium channel research, cellular endocytosis modulation, and broader epithelial sodium channel signaling pathways.

Supplied as a solid (molecular weight: 229.63; chemical formula: C6H8ClN7O), Amiloride (MK-870) is intended exclusively for research use, with optimal storage at -20°C to preserve stability. Notably, solutions should be prepared fresh and used promptly due to limited long-term stability. Shipping is optimized for molecular integrity, employing Blue Ice for small molecules and Dry Ice for modified nucleotides.

Step-by-Step Workflow: Enhancing Experimental Protocols with Amiloride

1. Preparing Amiloride (MK-870) Solutions

• Weighing and Dissolution: Accurately weigh Amiloride solid. Dissolve in DMSO or water to prepare a stock solution (commonly 10–100 mM).
• Aliquoting: Aliquot stock to minimize freeze-thaw cycles. Store at -20°C, protected from light.
• Working Solution: Dilute freshly to desired concentrations in cell culture media or buffer, typically ranging from 1–100 μM depending on assay sensitivity and cell type.

2. Integrating Amiloride in Sodium Channel and Endocytosis Assays

1. Cell Pre-Treatment: Incubate target cells (e.g., epithelial, renal, or airway models) with Amiloride at optimized concentrations 30–60 minutes prior to introducing stimuli (e.g., sodium load, viral particles, or receptor agonists).
2. Functional Assays: Assess changes in transepithelial sodium transport using Ussing chambers, patch-clamp electrophysiology, or fluorescent sodium indicators.
3. Endocytic Pathway Dissection: Pair Amiloride with other pathway inhibitors (e.g., chlorpromazine for clathrin-mediated endocytosis) to map receptor-mediated uptake or viral entry routes. For example, in the study by Wang et al. (2018), Amiloride was employed alongside a suite of inhibitors to differentiate endocytic mechanisms in grass carp kidney cells.
4. Downstream Readouts: Quantify outcomes using qPCR (for viral or gene expression), ELISA, Western blotting, or live-cell imaging as suited to your research question.

3. Data Normalization and Controls

• Always include vehicle controls (e.g., DMSO alone) and, if possible, positive/negative controls for each pathway interrogated.
• Confirm specificity by performing parallel experiments with alternative channel or receptor inhibitors.

Advanced Applications and Comparative Advantages

Amiloride (MK-870) is at the forefront of translational sodium channel research, offering unique advantages for both foundational and disease-oriented studies:

• Cystic Fibrosis Research: By inhibiting ENaC, Amiloride reduces hyperactive sodium absorption—a pathogenic hallmark in cystic fibrosis airway epithelia. This action has enabled modeling of disease phenotypes and preclinical screening of corrective interventions (complementary insights here).
• Hypertension Research: As sodium reabsorption in renal epithelia is a key driver of salt-sensitive hypertension, Amiloride's selective ENaC inhibition allows for precise dissection of blood pressure regulation, mirroring clinical responses to thiazide and potassium-sparing diuretics (further discussed here).
• Cellular Endocytosis Modulation: Amiloride disrupts macropinocytosis and other sodium-dependent endocytic processes, making it essential for studies of viral entry, nanoparticle uptake, and receptor trafficking. However, as shown in Wang et al. (2018), its effect is pathway-specific: while Amiloride did not block clathrin-mediated endocytosis of grass carp reovirus, it remains effective in other systems and endocytic routes—highlighting the importance of context-driven experimental design.
• Pathway Dissection: The dual action on ENaC and uPAR enables integrated exploration of epithelial sodium channel and urokinase receptor signaling pathways, supporting cross-talk studies and systems-level analyses. Comparative reviews such as this article extend on mechanistic details for translational applications.

In direct comparison to inhibitors with single-target specificity, Amiloride (MK-870) enables multi-dimensional interrogation of epithelial transport and receptor-mediated signaling, positioning it as a preferred tool for multi-pathway experimental designs.

Troubleshooting and Optimization Tips

• Solubility Issues: If Amiloride is slow to dissolve, gently warm the solution (avoid temperatures >37°C) and vortex. Verify full solubilization visually before use.
• Assay Sensitivity: Titrate concentration in increments (e.g., 1, 10, 50, 100 μM) to determine the minimal effective dose for pathway inhibition without cytotoxicity. Literature reports EC₅₀ values for ENaC inhibition typically in the low micromolar range (e.g., 1–10 μM in epithelial cells).
• Temporal Optimization: Pre-incubation times may require adjustment: for acute ion transport assays, 10–30 min is often sufficient; for endocytic modulation, 30–60 min may be optimal. Always monitor for off-target or delayed effects.
• Specificity Controls: Given Amiloride's dual action, parallel use of alternative ENaC or uPAR inhibitors (or genetic knockdown/knockout models) can confirm pathway specificity.
• Stability Considerations: Prepare fresh working solutions immediately before use, as long-term storage of diluted Amiloride may lead to reduced activity. Aliquot stocks to avoid repeated freeze-thaw cycles.
• Data Reproducibility: Standardize assay conditions and validate reagent integrity (e.g., via HPLC or MS) if unexpected results occur.

Future Outlook: Expanding the Impact of Amiloride (MK-870)

The future of sodium channel and receptor-mediated pathway research is increasingly interdisciplinary. Amiloride (MK-870) is poised to play a pivotal role in:

• Personalized Disease Models: Integration into patient-derived organoids and tissue chips for cystic fibrosis or hypertension research to tailor therapeutic strategies.
• Advanced Endocytosis Studies: Leveraging live-cell imaging and super-resolution microscopy to map real-time effects of Amiloride on endocytic trafficking in primary cells and disease models.
• Multi-Omics Profiling: Combining Amiloride treatment with transcriptomic and proteomic readouts to unravel the systemic effects of ENaC and uPAR modulation across cell types.

New discoveries, such as those highlighted by recent mechanistic reviews, envision APExBIO’s Amiloride (MK-870) as a cornerstone for innovative translational studies—bridging molecular insights with clinical relevance, especially as our understanding of the epithelial sodium channel and urokinase receptor signaling pathways deepens.

Conclusion

Amiloride (MK-870) offers unmatched versatility and precision for sodium channel research, endocytosis modulation, and pathway dissection. Its proven utility in both fundamental and disease-focused workflows—backed by robust comparative studies and high reproducibility—makes it an indispensable reagent for the next generation of translational scientists. For researchers seeking validated, reproducible, and innovative tools, APExBIO remains the trusted supplier of choice.